Invasive cutaneous malignant melanoma in Sweden, 1990–1999

The objective of the current study was to compile prospective, population‐based data on cutaneous invasive melanomas in Sweden during the period from 1990 to 1999, to describe and analyze survival data and prognostic factors, and to make comparisons with previously published Swedish and international data.

[1]  K. Czene,et al.  Cancer risks in first‐generation immigrants to Sweden , 2002, International journal of cancer.

[2]  J. Doré,et al.  Time trends of cutaneous melanoma in Queensland, Australia and Central Europe , 2002, Cancer.

[3]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[4]  M. Coleman,et al.  Cancer survival increases in Europe, but international differences remain wide. , 2001, European journal of cancer.

[5]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[8]  B. Armstrong,et al.  Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.

[9]  C. Ingvar,et al.  Long term results of a randomized study by the Swedish Melanoma Study Group on 2‐cm versus 5‐cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm , 2000, Cancer.

[10]  U. Ringborg,et al.  Trends in mortality from malignant melanoma in Sweden, 1970–1996 , 2000, Cancer.

[11]  D. Czarnecki,et al.  Is the incidence of malignant melanoma decreasing in young Australians? , 2000, Journal of the American Academy of Dermatology.

[12]  C. la Vecchia,et al.  Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age , 1999, International journal of cancer.

[13]  J. Redburn,et al.  Improving survival of melanoma patients in Europe since 1978. EUROCARE Working Group. , 1998, European journal of cancer.

[14]  S. Aamdal,et al.  Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. , 1998, European journal of cancer.

[15]  U. Ringborg.  Review: Cutaneous Malignant Melanoma , 1996 .

[16]  U. Ringborg,et al.  Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: A randomized study by the Swedish Melanoma Study Group , 1996, Cancer.

[17]  G. Fagerberg,et al.  Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. , 1995, Acta oncologica.

[18]  J. Wersäll,et al.  Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study Group , 1994, Melanoma research.

[19]  H. Adami,et al.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. , 1994, British Journal of Cancer.

[20]  H. Olsson,et al.  Cutaneous malignant melanoma in South Sweden 1965, 1975, and 1985. A histopathologic review , 1994, Cancer.

[21]  H. Olsson,et al.  Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review. , 1994, Cancer.

[22]  Stephen K. Jones,et al.  Cutaneous malignant melanoma of the head and neck , 1993, Cancer.

[23]  H. Adami,et al.  Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: A report from the swedish melanoma study group , 1993, Cancer.

[24]  F. Levi,et al.  Cancer incidence in five continents, vol. VI , 1993 .

[25]  C. Ingvar,et al.  Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  N. Cascinelli,et al.  Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. , 1991, Archives of surgery.

[27]  K Magnus,et al.  The nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer , 1991, International journal of cancer.

[28]  S. Fisher.  Cutaneous malignant melanoma of the head and neck , 1989, The Laryngoscope.

[29]  H. Adami,et al.  Trends in survival from malignant melanoma: remarkable improvement in 23 years. , 1989, Journal of the National Cancer Institute.

[30]  B Mattsson,et al.  Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. , 1984, Acta radiologica. Oncology.

[31]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[32]  W. Grove.  Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[33]  A. Cochran,et al.  Difficulties encountered in the application of clark classification and the Breslow thickness measurement in cutaneous malignant melanoma , 1980, International journal of cancer.

[34]  H. Toutenburg.  Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S. , 1974 .

[35]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[36]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .